MTOR and neoplasm: Moreover, mTOR inhibitors act both on tumors and on immune cells; thus, one can hypothesize that the putative anti-tumor efficacy of mTOR inhibitors might be counterbalanced by their suppressive effects on immune cells, thereby building an immunosuppressive environment that facilitates tumor progression [497].